Every finding on record at Omni Hospice Services

Upon patient record review, 2 of 14 (Patient 3 and 4) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Patient 3 medication profile included “Brimonidine Tartrate 0.2% Ophth Solution 1 drop to affected eye twice daily” without identifying right or left eye, “Clonidine 0.1 mg tab 1 tab by mouth every 8 hours for hypertension if B/P >150 mm/hg not to exceed 3 tabs in 24 hours” with unclear instructions, and “Atropine Sulfate 1% Ophthalmic Solution 1 drop to affected eye four times daily” without identifying right or left eye. Patient 4 medication profile included “Triamcinolone Acetonide 0.025% topical cream apply twice daily x 10 days to the affected areas without location identified and “Hydrocortisone 1% topical cream apply to affected area twice a day as needed” without location identified.

Upon patient record review, 2 of 14 (Patient 3 and 4) did not have evidence the plan of care must include all services necessary for the palliation and management of the terminal illness and related conditions, including medications and treatments. Patient 3 plan of care included “Brimonidine Tartrate 0.2% Ophth Solution 1 drop to affected eye twice daily” without identifying right or left eye, “Clonidine 0.1 mg tab 1 tab by mouth every 8 hours for hypertension if B/P >150 mm/hg not to exceed 3 tabs in 24 hours” with unclear instructions, and “Atropine Sulfate 1% Ophthalmic Solution 1 drop to affected eye four times daily” without identifying right or left eye. Patient 4 plan of care included “Triamcinolone Acetonide 0.025% topical cream apply twice daily x 10 days to the affected areas without location identified and “Hydrocortisone 1% topical cream apply to affected area twice a day as needed” without location identified.

Upon patient record review, 2 of 14 (Patient 1 & 2) did not have evidence the plan of care included all services necessary for the palliation and management of the terminal illness and related conditions, including equipment and supply needs. Patient 1 initial assessment identified walker, cane and shower chair in the home but this was not identified on the plan of care. Patient 2 initial assessment identified cane and hospital bed in the home but was not identified on the plan of care.